Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
59 Leser
Artikel bewerten:
(0)

India Pediatric Drugs and Vaccines Market Outlook 20172021 - India's Emergence as a Global Destination for Clinical Trials - Research and Markets

DUBLIN, Apr 3, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "India Pediatric Drugs and Vaccines Market Outlook to 2021 - Rise in Prevalence of Chronic Diseases and Inclusion of Several New Vaccines in National Immunization Programme to Shape Future Growth" report to their offering.

Research and Markets Logo

The report titled "India Pediatric Drugs and Vaccines Market Outlook to 2021 provides a comprehensive analysis of the pediatric drugs and vaccines market in India and covers market size and segmentation of overall market by drugs and vaccines.

The report covers the further segmentations of different spaces such as Drugs and Vaccines into sub segments based on their individual characteristics. The sub segments of Drugs (Patented and Generic, Treatment and Management, Drug Classes, Prescription and OTC, Online and Offline) are then considered separately and analysis on them has been done individually. Similarly, the sub segments of Vaccines (Monovalent and Multivalent, Technology, Indication) have also been considered.

The report covers detailed profiles of leading players in the different sub segments in the market. The potential and future outlook has been individually discused for India Pediatric Drug and Vaccine market.

The report provides detailed analysis of segments, trends & developments, growth drivers and major restraints and challenges within the industry. The report also serves as a benchmark for existing players and for new players who wish to capitalize on the market potential and investors who are looking forward to venture into pediatric drugs and vaccines market in India.


Key Topics Covered:

1. Executive Summary

2. Value Chain Analysis of India Pediatric Drugs and Vaccines Market

3. India Pediatric Drugs and Vaccines Market, FY'2011-FY'2016

4. India Pediatric Drugs Market Introduction and Size, FY'2011-FY'2016

5. India Pediatric Drugs Market Segmentation

6. Competitive Landscape of Major Players in India Pediatric Drugs Market

7. India Pediatric Drugs Market Future Outlook, FY'2017-FY'2021

8. India Pediatric Vaccines Market Introduction and Size, FY'2011-FY'2016

9. India Pediatric Vaccines Market Segmentation

10. Competitive Landscape of Major Players in India Pediatrics Vaccine Market

11. Pipeline Analysis of Global and India Pediatric Vaccines market

12. India Pediatric Vaccines Market Future Outlook, FY'2017-FY'2021

13. Government Regulations in India Pediatric Drugs and Vaccines Market

14. Porter Five Forces Analysis in India Pediatric Drugs and Vaccines Market

15. Issues and Challenges in India Pediatric Drugs and Vaccines Market

16. Analyst Recommendations

17. Macroeconomic Factors in India Pediatric Drugs and Vaccines Market

Companies Mentioned

  • Sun Pharmaceuticals
  • Lupin Pharmaceuticals
  • Cipla
  • Dr. Reddy's Laboratories
  • Abbott India
  • Serum Institute of India
  • Panacea Biotec
  • Bharat Biotech
  • GSK Pharmaceuticals
  • Biological E Limited

For more information about this report visit http://www.researchandmarkets.com/research/jdbmrr/india_pediatric


Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.